Author

Ruijuan Zheng

Shanghai Pulmonary HospitalORCID 0000-0002-9140-2624Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Xiaochen HuangiD· 2 shared Baoxue GeiD· 1 shared Chen QiuiD· 1 shared Cheng PengiD· 1 shared Haipeng LiuiD· 1 shared Hongyu ChengiD· 1 shared Hua YangiD· 1 shared Jianxia CheniD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Xiaochen HuangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 9, 2025

A BCG toxic effector induces mitochondrial DNA compaction to refrain protective immunity

Cheng Peng, Chen Qiu, Jingping Huang…·Baoxue Ge

This study shows that BCG effector PE18 induces mitochondrial DNA compaction to suppress trained immunity and protective immunity against Mtb.

DOI 10.1101/2025.11.09.687409

humanDNA methylation

𝕏 PostBluesky

ImmunologyeLifePeer-reviewedNov 4, 2024

Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth

Lianhua Qin, Junfang Xu, Jianxia Chen…·Haipeng Liu

The paper identifies galectin-9 and AG-specific antibodies that inhibit Mtb growth by targeting arabinogalactan, offering a new immunotherapeutic strategy for TB.

1 citation

humanproteomics

𝕏 PostBluesky